Copyright
©The Author(s) 2015.
World J Hepatol. Aug 28, 2015; 7(18): 2133-2135
Published online Aug 28, 2015. doi: 10.4254/wjh.v7.i18.2133
Published online Aug 28, 2015. doi: 10.4254/wjh.v7.i18.2133
Table 1 Major cancer genes involved in the pathogenesis of hepatocellular carcinoma
| Gene | Type | Pathways |
| MYC | Oncogene | Proliferation control |
| EGF | Oncogene | EGFR signaling (mitogenic signaling) |
| TGFA | Oncogene | EGFR signaling (mitogenic signaling) |
| APC | Tumor suppressor gene | Wnt-signaling |
| PTEN | Tumor suppressor gene | PI3K/Akt/mTOR signaling |
| AKT | Oncogene | PI3K/Akt/mTOR signaling |
| HGF | Oncogene | Growth factor |
| MET | Oncogene | Growth factor receptor |
| PDGFR | Oncogene | Growth factor receptor |
| RAS | Oncogene | Ras/MAPK signaling |
| P53 | Tumor suppressor gene | Stress response, cell cycle inhibition |
| E2F1 | Oncogene | Cell cycle |
| CCND1 | Oncogene | Cell cycle |
| Telomerase | Oncogene | Cell senescence |
- Citation: Wong GLH. Optimal surveillance program for hepatocellular carcinoma - getting ready, but not yet. World J Hepatol 2015; 7(18): 2133-2135
- URL: https://www.wjgnet.com/1948-5182/full/v7/i18/2133.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i18.2133
